In a young adult with a three‑day history of an itchy, flat rash that began on the hands, spread to the feet, legs, arms, and back, with no fever, headache, recent sexual contact, urinary symptoms, or known drug allergies, and partial improvement after diphenhydramine (Benadryl), what is the most likely diagnosis and recommended management?

Diagnosis and Management of Acute Urticaria

This patient most likely has acute urticaria (hives), and management should focus on continuing oral second-generation H1-antihistamines (such as cetirizine or loratadine) rather than diphenhydramine, with no need for systemic corticosteroids given the self-limited nature and partial improvement already observed.

Clinical Reasoning

The presentation is classic for acute urticaria: an itchy, flat rash with characteristic acral (hands and feet) onset that spread centripetally over 3 days, occurring in flare-ups, with spontaneous improvement and no systemic symptoms (no fever, headache, or other organ involvement). The absence of sexual contact, urinary symptoms, or ulcers makes secondary syphilis unlikely despite the palmoplantar distribution.

Why Not Continue Diphenhydramine?

While the patient has been using Benadryl (diphenhydramine) with some relief, this first-generation antihistamine is suboptimal for ongoing management 1. The FDA label specifically warns about marked drowsiness—which the patient is already experiencing—and impaired ability to drive or operate machinery 1. More importantly, recent evidence demonstrates that:

• Intravenous cetirizine (a second-generation antihistamine) is noninferior to diphenhydramine for acute urticaria but with significantly less sedation (sedation score change 0.1 vs 0.5, P=.03), fewer adverse events (3.9% vs 13.3%), and lower rates of return visits (5.5% vs 14.1%) 2
• The sedative effects of diphenhydramine provide no therapeutic advantage—the relief comes from H1-receptor blockade, not sedation 3

Recommended Management Algorithm

Immediate Management (Days 1-7)

1. Switch to a second-generation H1-antihistamine at standard dosing:

   • Cetirizine 10 mg once daily, OR
   • Loratadine 10 mg once daily
   • These provide 24-hour coverage without sedation and are safe for driving 2

2. Do NOT add systemic corticosteroids at this stage. Recent systematic review evidence shows that adding prednisone to antihistamines did not improve symptoms of acute urticaria compared to antihistamines alone in 2 out of 3 RCTs 4. Given the patient's already improving symptoms, corticosteroids would add unnecessary risk without clear benefit.

If Symptoms Persist Beyond 7 Days

1. Increase antihistamine dose up to 4-fold (e.g., cetirizine 10 mg up to four times daily) before considering other interventions 5

2. Consider H2-receptor antagonist addition only if standard-dose second-generation antihistamines fail. Limited evidence suggests ranitidine combined with an H1-antihistamine may provide additional benefit (RR 1.59,95% CI 1.07-2.36) 6, though the evidence quality is weak.

Key Diagnostic Considerations

The British Association of Dermatologists guidelines emphasize investigating potential triggers 7:

• Recent exposures: cosmetics, personal-care products, new clothing, gloves, or bandages
• Activities: recent travel (the patient mentions swimming in waterfalls—consider leptospirosis if fever develops 8), new recreational activities, home improvements
• Occupational factors: new workplace exposures, chemicals, or protective equipment
• Wash products: harsh emulsifiers/surfactants can trigger dermatitis in predisposed individuals

Important caveat: If this rash persists beyond 6 weeks, it becomes chronic spontaneous urticaria (CSU), requiring patch testing to distinguish allergic contact dermatitis from other causes, as clinical features alone are unreliable 7, 9.

What to Avoid

• Long-term diphenhydramine use: Causes cumulative sedation, anticholinergic effects (dry mouth, urinary retention, blurred vision), and does not prevent recurrence 1
• Routine corticosteroids for mild-moderate acute urticaria: No proven benefit and adds unnecessary side effects 4
• Topical antihistamines: Can cause contact dermatitis themselves, particularly doxepin cream 10

When to Escalate Care

Refer to dermatology or allergy if:

• Symptoms persist beyond 6 weeks (chronic urticaria)
• Failure to respond to quadruple-dose second-generation antihistamines
• Development of angioedema, particularly laryngeal involvement (requires immediate epinephrine 0.5 mL of 1:1000 IM) 11
• Suspicion of urticarial vasculitis (painful rather than itchy lesions, lasting >24 hours, leaving bruising)

The family history of requiring "an injection" for similar rash may indicate severe urticaria or anaphylaxis in the relative—ensure this patient understands warning signs of anaphylaxis (throat tightness, difficulty breathing, dizziness) and when to seek emergency care.